Cure8 research brief
Why This Matters
Malnutrition and growth failure at diagnosis are common in children with IBD—especially Crohn’s—and can indicate higher inflammatory burden. Monitoring and addressing nutrition and growth is important because most children improve over time, but early identification guides clinical care.
Who Should Pay Attention
Pediatric patients with IBD, parents and caregivers of children with IBD, and pediatric gastroenterologists/nutrition teams.
Study Snapshot
What To Know
This multicentre retrospective cohort study in children with Crohn’s disease or ulcerative colitis examined nutritional status and linear growth at diagnosis and during follow-up, and whether underweight or stunting at diagnosis were linked to later clinical outcomes.
Key findings reported in the abstract: about 23% of the 128 children were underweight at diagnosis (more common in Crohn’s than UC), and 7% had growth failure (stunting). Most underweight children improved their BMI over a mean follow-up of ~29 months.
The authors report that baseline underweight was not independently associated with higher risk of relapse after adjustment.
Keep In Mind
This record is an abstracted multicentre retrospective cohort study reported in Nutrients. The available text is the article abstract (structured summary); the brief above is grounded in that abstract rather than a full peer-reviewed narrative or individual patient data. The study reports associations but does not establish causation.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.